{"id":12287,"date":"2025-08-04T14:56:57","date_gmt":"2025-08-04T14:56:57","guid":{"rendered":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2025\/08\/04\/biontech-auf-kurs-richtung-krebsmedikament-und-deutlich-weniger-verlust\/"},"modified":"2025-08-04T14:56:57","modified_gmt":"2025-08-04T14:56:57","slug":"biontech-auf-kurs-richtung-krebsmedikament-und-deutlich-weniger-verlust","status":"publish","type":"post","link":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/2025\/08\/04\/biontech-auf-kurs-richtung-krebsmedikament-und-deutlich-weniger-verlust\/","title":{"rendered":"Biontech: Auf Kurs Richtung Krebsmedikament und deutlich weniger Verlust"},"content":{"rendered":"<p>Der Biotechkonzern kommt bei der Entwicklung seiner Krebstherapien weiter voran. Dazu tragen auch die Kooperation mit dem US-Konzern Bristol Myers Squibb und die \u00dcbernahme von Curevac bei.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Der Biotechkonzern kommt bei der Entwicklung seiner Krebstherapien weiter voran. Dazu tragen auch die Kooperation mit dem US-Konzern Bristol Myers Squibb und die \u00dcbernahme von Curevac bei.<\/p>\n","protected":false},"author":1,"featured_media":12288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-12287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/12287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/comments?post=12287"}],"version-history":[{"count":0,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/posts\/12287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media\/12288"}],"wp:attachment":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/media?parent=12287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/categories?post=12287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo76e71539\/wp-json\/wp\/v2\/tags?post=12287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}